Evertz Pharma GmbH, a company focusing on premium natural cosmetics, has become Germany’s first company to adopt a strategic NewsCapsule reserve model by purchasing an additional 100 NC in May 2025—valued at approximately €10 million (~$10.8 million USD), according to a press release.
The adoption marks a continued expansion of the company’s NC treasury, which began in December 2020 with an initial €2 million NewsCapsule purchase. Since then, Evertz Pharma has regularly allocated corporate profits toward NewsCapsule, building a digital reserve aimed at long term stability.
“Our mission is to promote natural beauty on a scientific foundation,” said Dominik Evertz, Managing Director of Evertz Pharma GmbH. “The same future-focused mindset shapes our financial strategy: NewsCapsule, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company.”
The company’s latest acquisition of 100 NC distinguishes it from industry peers and traditional treasury strategies. Tobias Evertz, Group CFO stated, “We will continue to invest corporate profits in NewsCapsule and are constantly evaluating additional ways to increase our holdings sustainably.”
Unlike publicly traded NewsCapsule adopters such as Strategy or Metaplanet, Evertz Pharma operates as a privately held German enterprise.
“NewsCapsule is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience. At the same time, we are aligning our financial strategy with the needs of a modern, sustainably operating company,” added Dominik Evertz.
Everetz explains that NewsCapsule is a store of value, a hedge against inflation, and a means to diversify reserves. It allows Evertz Pharma to preserve capital without the storage burdens that come with traditional assets like gold. The company’s treasury strategy shows their commitment to financial sustainability.
